SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Starfighters Space Inc

Starfighters Space Inc. (FJET), a recent IPO in the commercial space and hypersonic sectors, is experiencing a massive surge, driven by intense community FOMO and a perceived short squeeze. Investors are actively discussing its low float and unique air-launch capabilities, positioning it within a currently hot aerospace sector. The stock is generating significant conversation about its potential for explosive upward movement.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent drill results revealing exceptionally high-grade silver, which is fueling community excitement about its significant resource potential amid surging precious metals prices. The stock's dramatic uptick also sparks widespread discussion regarding prior corporate divestment and prominent investor accumulation, leading to strong speculation about a potential short squeeze and substantial long-term value.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Tempe, AZ.

First Solar Inc

First Solar is trending amid strong bullish sentiment, fueled by its critical role in supplying the surging 'AI energy' demand for data centers and a series of positive analyst upgrades. The company's strategic position as a leading U.S. solar manufacturer, highlighted by its indirect link to Google's clean energy expansion through a key customer, underpins community discussions about its significant growth potential. Investors are actively discussing First Solar's leadership within the renewable energy sector as it addresses increasing power demands and benefits from domestic manufacturing policies.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid analyst upgrades, including a $45 price target from Jefferies, and anticipation for its CES 2026 showcase of commercial quantum computing applications. The community is sharply divided, with bulls highlighting its "quantum supremacy in optimization" and potential as an AI enabler, while bears decry it as a "manipulated pump" detached from fundamental value. This intense debate around its role in the emerging quantum sector is driving significant conversation.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending with significant bullish momentum, largely fueled by the highly anticipated NASA Lunar Terrain Vehicle (LTV) contract award, which the community believes is imminent and could trigger a substantial short squeeze. This excitement is further amplified by recent analyst upgrades, the acquisition of Lanteris Space Systems, and broader government support for the burgeoning lunar infrastructure sector, positioning LUNR as a key player in the ongoing space race.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is surging following news of a significant $816 million prime contract from the U.S. Space Development Agency for missile-tracking satellites, capping a year of record-breaking Electron launches with 100% mission success. The community is highly bullish, viewing this as a transformative move solidifying RKLB's role as a vertically integrated space and defense prime contractor, with widespread anticipation of continued sector growth fueled by a potential SpaceX IPO.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following news of its planned all-stock merger with fusion energy company TAE Technologies, valued at over $6 billion, coupled with recent strategic Bitcoin purchases. The community is actively debating the stock's future, with many anticipating a significant short squeeze and long-term energy potential, while others express skepticism over the company's unprofitability and the highly speculative nature of commercial fusion power.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense & Security Solutions is trending due to significant defense sector tailwinds, notably propelled by the US Army's plan for a massive drone procurement and the recently approved National Defense Authorization Act. The community is highlighting KTOS's robust Q3 performance, strategic acquisition of Orbit Technologies, and expanding manufacturing capabilities, underscoring its pivotal role in advancing unmanned systems and hypersonics for national security.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is generating significant community discussion amidst reports of major financial institutions exploring deeper crypto integration, alongside Trump Media's recent Bitcoin acquisition. This growing institutional interest is juxtaposed with MicroStrategy's recent pause in Bitcoin purchases, sparking debate about its capital allocation strategy. The community remains largely divided, with some anticipating a significant rally driven by long-term adoption while others voice frustration over persistent price resistance and concerns about market manipulation.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is generating significant discussion following mixed reactions to its Phase 2b REZOLVE-AA study results for alopecia areata, where its drug demonstrated efficacy but narrowly missed the primary endpoint before accounting for trial eligibility exclusions. This has ignited debate among the community, with many highlighting the drug's safety profile and differentiated mechanism as a strong catalyst for potential partnerships, a favorable outcome in the ongoing Lilly lawsuit, or even an acquisition, while others remain cautious due to past performance and dilution concerns.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mereo BioPharma Group (NASDAQ:MREO) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC restated a "buy" rating and set a $5.00 price objective on shares of Mereo BioPharma Group in a research note on Monday...

Mereo BioPharma Group plc - Sponsored ADR $MREO Shares Bought by Frazier Life Sciences Management L.P.

Frazier Life Sciences Management L.P. lifted its stake in shares of Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) by 20.7% during the second quarter, according to its most...

Mereo BioPharma Group Target of Unusually Large Options Trading (NASDAQ:MREO)

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Get Free Report) saw unusually large options trading on Thursday. Traders purchased 4,694 put options on the stock. This represents an...

Mereo BioPharma Group Target of Unusually High Options Trading (NASDAQ:MREO)

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock traders bought 15,681 call options on the stock...

Mereo BioPharma Group plc - Sponsored ADR $MREO Shares Sold by Tema Etfs LLC

Tema Etfs LLC decreased its holdings in shares of Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) by 84.3% in the second quarter, according to its most recent Form 13F filing...

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO) Receives Consensus Rating of "Moderate Buy" from Brokerages

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seven research firms that are covering the stock...

Mereo BioPharma Group (NASDAQ:MREO) Upgraded by Zacks Research to Hold Rating

Zacks Research raised shares of Mereo BioPharma Group from a "strong sell" rating to a "hold" rating in a report on Wednesday...

FY2025 Earnings Forecast for MREO Issued By Leerink Partnrs

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) - Research analysts at Leerink Partnrs cut their FY2025 earnings per share (EPS) estimates for shares of Mereo BioPharma Group in...

Leerink Partnrs Has Negative Forecast for MREO Q4 Earnings

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) - Equities research analysts at Leerink Partnrs reduced their Q4 2025 earnings per share (EPS) estimates for shares of Mereo...

Mereo BioPharma Group (NASDAQ:MREO) Releases Quarterly Earnings Results

Mereo BioPharma Group (NASDAQ:MREO - Get Free Report) issued its earnings results on Monday. The company reported ($0.01) EPS for the quarter...

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.

MREO
Mereo Biopharma

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MREO News

MREOMereo Biopharma